NCT03683641

Extracorporeal Shockwave Therapy in Insertional Achilles Tendinopathy

Completed NA Last updated 25 September 2018

What this trial tests

NA trial testing Extracorporeal Shock Wave Therapy in Insertional Achilles Tendinopathy in 30 participants. Completed in 31 July 2018.

Timeline

4 July 2016

Primary endpoint
28 June 2018

31 July 2018

Quick facts

Lead sponsor	Mahidol University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	30
Start date	4 July 2016
Primary completion	28 June 2018
Estimated completion	31 July 2018

Drugs / interventions tested

• Extracorporeal Shock Wave Therapy
• Sham Control group

Conditions studied

• Insertional Achilles Tendinopathy — all drugs for Insertional Achilles Tendinopathy →

Sponsor

Mahidol University

Who can join

Adults 18 to 70, any sex, with Insertional Achilles Tendinopathy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

There is still limited number of studies in the literature provides insufficient evidence to support the use of ESWT in the treatment of insertional Achilles tendinopathy and the contribution of a placebo effect to the shock waves was not assessed by previous study. So the investigators conducted a double-blinded randomized-controlled trial at the orthopedic out-patient clinic, Department of Orthopedics, Faculty of Medicine Ramathibodi Hospital between December 2016 and June 2018. Hypothesized that ESWT might be effective on insertional Achilles tendinopathy

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.